Potential treatments of COVID-19: Drug repurposing and therapeutic interventions

The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The infection is caused when Spike-protein (S-protein) present on the surface of SARS-CoV-2 interacts with human cell surface receptor, Angiotensin-converting enzyme 2 (ACE2). This bind...

Descripción completa

Detalles Bibliográficos
Autores principales: Raghav, Pawan Kumar, Mann, Zoya, Ahluwalia, Simran Kaur, Rajalingam, Raja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. 2023
Materias:
Full Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930377/
https://www.ncbi.nlm.nih.gov/pubmed/37059487
http://dx.doi.org/10.1016/j.jphs.2023.02.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930377/
https://www.ncbi.nlm.nih.gov/pubmed/37059487
http://dx.doi.org/10.1016/j.jphs.2023.02.004

Ejemplares similares